Skip to main content
SpringerLink
Log in

Psychiatric Disorders Associated with Traumatic Brain Injury

Optimal Treatment

  • Disease Management
  • Published:
CNS Drugs Aims and scope Submit manuscript

Summary

Traumatic brain injury (TBI) is a common phenomenon. Patients who have experienced an injury of this type can develop a range of psychiatric conditions [including depression, bipolar disorder, secondary mania, psychotic states (schizophreniform and paranoid), post-traumatic stress disorder, obsessive-compulsive disorder, phobic disorders, panic disorder and generalised anxiety disorder] and neuropsychiatric syndromes (including apathetic states and disorders of impulse control, ranging from irritability to severe aggression).

Despite the prevalence of these conditions, there have been no adequately controlled studies of epidemiology or pharmacological interventions. Hence, treatment approaches generally follow those seen in psychiatric conditions that occur in non-TBI populations. However, adjustments in these approaches must be made to account for the adverse effect profiles of the drugs used that may worsen cognitive function. Medications with prominent anticholinergic, anti-histaminergic or antidopaminergic effects should therefore not be used as first-line interventions. In addition, traditional antipsychotics may block synaptic plasticity and so should be used with caution in patients with TBI.

The management of apathetic syndromes is based on a paradigm of elevating dopaminergic (with or without noradrenergic) activity. Treatment of impulse control disorders centres on increasing serotonergic activity, along with the use of β-blockers (which may act through serotonin receptors) and anticonvulsants. Stimulant medications can also be useful for apathetic syndromes, and may enhance synaptic plasticity.

While this review predominantly discusses pharmacological interventions, they are only part of the essential multi-disciplinary management of patients with TBI. Cognitive, behavioural and family interventions should also be applied. Environmental management is often paramount, as the environment is frequently easier to alter than the disorders in the individual with TBI are to treat.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Field JH. Epidemiology of head injuries in England and Wales. London: Department of Health and Social Security, HM Stationery Office, 1976

    Google Scholar 

  2. Moscato BS, Treviso M, Willer BS. The prevalence of traumatic brain injuries and co-occurring disabilities in a national household survey of adults. J Neuropsychiatry Clin Neurosci 1994; 6: 134–42

    PubMed  CAS  Google Scholar 

  3. Kraus JF. Epidemiology of head injury. In: Cooper PR, editor. Head injury. 3rd ed. Baltimore: Williams and Wilkins, 1993: 1–25

    Google Scholar 

  4. Prigitano GP. Disturbances of self awareness of deficit after traumatic brain injury. In: Prigitano GP, Schacter DL, editors. Awareness of deficit after brain injury. New York: Oxford University Press, 1991: 111–26

    Google Scholar 

  5. London PA. Some observations on the course of events after severe injury of the head. J R Coll Surg Eng 1967; 41: 460–79

    CAS  Google Scholar 

  6. Frank RG. Families and rehabilitation. Brain Inj 1994; 8: 193–5

    Article  PubMed  CAS  Google Scholar 

  7. Uomoto JM, Esselman PC. Traumatic brain injury and chronic pain: differential types and rates by head injury severity. Arch Phys Med Rehabil 1993; 74: 61–4

    PubMed  CAS  Google Scholar 

  8. Lahz S, Bryant RA. Incidence of chronic pain following traumatic brain injury. Arch Phys Med Rehabil 1996; 77: 889–91

    Article  PubMed  CAS  Google Scholar 

  9. Rutherford WH, Merrett JD, McDonald JR. Sequelae of concussion caused by minor head injuries. Lancet 1977; I: 1–4

    Article  Google Scholar 

  10. Schoenhuber R, Gentilini M. Anxiety and depression after mild head injury: a case control study. J Neurol Neurosurg Psychiatry 1988; 5: 722–4

    Article  Google Scholar 

  11. Mobayed M, Dinan TG. Buspirone/prolactin response in post head injury depression. J Affect Dis 1990; 19(4): 237–41

    Article  PubMed  CAS  Google Scholar 

  12. Brooks DN, Campsie L, Symington C, et al. The five year outcome of severe blunt head injury: a relatives view. J Neurol Neurosurg Psychiatry 1986; 49: 764–70

    Article  PubMed  CAS  Google Scholar 

  13. Federoff JP, Starkstein SE, Forrester AW, et al. Depression in patients with acute traumatic brain injury. Am J Psychiatry 1992; 149: 918–23

    Google Scholar 

  14. Kinsella G, Moran X, Ford B, et al. Emotional disorder and its assessment within the severe head-injured population. Psychol Med 1988; 18: 57–63

    Article  PubMed  CAS  Google Scholar 

  15. Levin HS, Grossman RG. Behavioural sequelae of closed head injury: a quantitative study. Arch Neurol 1978; 35: 720–7

    Article  PubMed  CAS  Google Scholar 

  16. Oddy M, Coughlan T, Tyerman A, et al. Social adjustment after closed head injury: a further follow-up seven years after injury. J Neurol Neurosurg Psychiatry 1985; 48: 564–8

    Article  PubMed  CAS  Google Scholar 

  17. Tyerman A, Humphrey M. Changes in self concept following severe head injury. Int J Rehabil Res 1984; 7: 11–23

    Article  PubMed  CAS  Google Scholar 

  18. van Zomeran A, van den Burg W Residual complaints of patients two years after severe head injury. J Neurol Neurosurg Psychiatry 1985: 14: 21–8

    Article  Google Scholar 

  19. Varney NR, Hartzke JS, Roberts RJ. Major depression in patients with closed head injury. Neuropsychology 1987; 1: 7–9

    Google Scholar 

  20. Weddell R, Oddy M, Jenkins D. Social adjustment after rehabilitation: a two-year follow up of patients with severe head injury. Psychosom Med 1980; 10: 257–63

    Article  CAS  Google Scholar 

  21. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Association, 1980

    Google Scholar 

  22. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. rev. Washington, DC: American Psychiatric Association, 1987

    Google Scholar 

  23. Robinson RG, Jorge R. Mood disorders. In: Silver JM, Yudofsky SC, Hales RE, editors. Neuropsychiatry of traumatic brain injury. Washington, DC: American Psychiatric Press, 1994: 219–50

    Google Scholar 

  24. Jorge RE, Robinson RG, Arndt SV. Are depressive symptoms specific for depressed mood in traumatic brain injury? J Nerv Ment Dis 1993; 181: 91–9

    Article  PubMed  CAS  Google Scholar 

  25. Jorge RE, Robinson RG, Arndt SV, et al. Depression and traumatic brain injury: a longitudinal study. J Affect Dis 1993; 27: 233–43

    Article  PubMed  CAS  Google Scholar 

  26. Jorge RE, Robinson RG, Arndt SV, et al. Comparison between acute and delayed onset depression following traumatic brain injury. J Neuropsychiatry Clin Neurosci 1993; 5: 43–9

    PubMed  CAS  Google Scholar 

  27. Jorge RE, Robinson RG, Starkstein SE, et al. Depression and anxiety following traumatic brain injury. J Neuropsychiatry Clin Neurosci 1993; 5: 369–74

    PubMed  CAS  Google Scholar 

  28. Lishman WA. Physiogenesis and psychogenesis in the ‘post-concussional’ syndrome. Br J Psychiatry 1988; 153: 460–9

    Article  PubMed  CAS  Google Scholar 

  29. van Zomeran AH, Saan RJ. Psychological and social sequelae of severe head injury. In: Braakman R, editor. Handbook of clinical neurology. Vol. 13. Head injury. Amsterdam: Elsevier, 1990: 397–420

    Google Scholar 

  30. Prigitano GP. Psychiatric aspects of head injury: problem areas and suggested guidelines for research. In: Levin HS, Eisenberg HM, editors. Neurobehavioural recovery from head injury. Oxford: Oxford University Press, 1987: 215–32

    Google Scholar 

  31. Grafman J, Vance SC, Swingartner H, et al. The effects of lateralised frontal lesions on mood regulation. Brain 1986; 109: 1127–48

    Article  PubMed  Google Scholar 

  32. Lishman WA. Brain damage in relation to psychiatric disability after head injury. Br J Psychiatry 1968; 114: 373–410

    Article  PubMed  CAS  Google Scholar 

  33. Tomarken AJ, Davidson RJ. Frontal brain activation in repressors and nonrepressors. J Abnorm Psychol 1994; 103: 339–49

    Article  PubMed  CAS  Google Scholar 

  34. Ross ED. Non verbal aspects of language. Neurol Clin 1993; 11(1): 9–23

    PubMed  CAS  Google Scholar 

  35. Saran AS. Depression after minor closed head injury: role of dexamathasone depression test and antidepressants. J Clin Psychiatry 1985; 46(8): 335–8

    PubMed  CAS  Google Scholar 

  36. Silver JM, Hales RE, Yudofsky SC. Neuropsychiatric aspects of traumatic brain injury. In: Yudofsky SC, Hales RE, editors. The American psychiatric press textbook of neuropsychiatry. Washington, DC: American Psychiatry Pres, 1992: 363–95

    Google Scholar 

  37. Dinan TG, Mobayed M. Treatment resistance of depression after head injury: a preliminary study of amitriptyline response. Acta Psychiatr Scand 1992; 85: 292–4

    Article  PubMed  CAS  Google Scholar 

  38. Cassidy JW. Fluoxetine: a serotonergically active antidepressant. J Head Trauma Rehabil 1989; 4: 67–9

    Article  Google Scholar 

  39. Newburn GM, Edwards RA, Thomas H, et al. A comparison of the efficacy and tolerability of moclobemide given as a single daily dose or as three divided doses per day for the treatment of patients with a major depressive episode (DSM-3-R). J Clin Psychopharmacol 1995; 15 Suppl. 2: 10–5

    Article  Google Scholar 

  40. Williams R, Edwards RA, Newburn GM, et al. A double-blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders. Int Clin Psychopharmacol 1993; 7: 155–8

    Article  PubMed  CAS  Google Scholar 

  41. Newburn GM, Fraser AR, Menkes DB, et al. A double-blind trial of moclobemide versus amitriptyline in the treatment of depressive disorders. Aust NZ J Psychiatry 1990; 24: 475–9

    Article  CAS  Google Scholar 

  42. Silverman M. Organic stupor subsequent to a severe head injury treated with ECT. Br J Psychiatry 1964; 110: 645–50

    Article  Google Scholar 

  43. Ruedrich I, Chu CC, Moore SI. ECT for major depression in a patient with acute brain trauma. Am J Psychiatry 1983; 140: 928–9

    PubMed  CAS  Google Scholar 

  44. Devane CL. Comparative safety and tolerability of selective serotonin reuptake inhibitors. Hum Psychopharmacol 1995; 10 Suppl.: S185–193

    Article  CAS  Google Scholar 

  45. Andersen BS, Mikkelsen W, Vesteragen A, et al. No influence of the antidepressant paroxetine on carbamazepine, valproate and phenytoin. Epilepsy Res 1991; 10: 201–4

    Article  PubMed  CAS  Google Scholar 

  46. Remeron — scientific information. Oss, The Netherlands

  47. Hoffman-La Roche Safety database. Basel, 1998

  48. Hoheisel HP, Walch R. Uber manisch-depressive und uerwandte verstimmungszus tande nach Hirnverletzung. Arch Psychiatr Nervenkrankheiten 1952; 188: 1–25

    Article  CAS  Google Scholar 

  49. Lishman WA. Organic psychiatry: the psychological consequences of cerebral disorder. 2nd ed. Oxford: Blackwell Scientific Publications, 1987

    Google Scholar 

  50. Jorge RE, Robinson RG, Starkstein SE, et al. Manic syndromes following traumatic brain injury. Am J Psychiatry 1993; 155: 916–21

    Google Scholar 

  51. Shukla S, Cook BL, Mukherjee S, et al. Mania following head trauma. Am J Psychiatry 1987; 144: 93–6

    PubMed  CAS  Google Scholar 

  52. Starkstein SE, Pearlson GD, Boston JD, et al. Mania following head trauma: a controlled study of causative factors. Arch Neurol 1988; 44: 1069–73

    Article  Google Scholar 

  53. Starkstein SE, Boston JD, Robinson RG. Mechanisms of mania after brain injury: 12 case reports and review of the literature. J Nerv Ment Dis 1988; 176: 87–100

    Article  PubMed  CAS  Google Scholar 

  54. Starkstein SE, Mayberg HS, Berthier ML, et al. Secondary mania: neuroradiological and metabolic findings. Am Neurol 1990; 27: 652–9

    Article  CAS  Google Scholar 

  55. Stewart JT, Nemsath RN. Bipolar illness following traumatic brain injury: treatment with lithium and carbamazepine. J Clin Psychiatry 1988; 49: 74–5

    PubMed  CAS  Google Scholar 

  56. Bouvy PF, van de Wetering BJM, Mearwaldt JD, et al. A case of organic brain syndrome following head injury successfully treated with carbamazepine. Acta Psychiatr Scand 1988; 77: 361–3

    Article  PubMed  CAS  Google Scholar 

  57. Pope HG, McElroy SL, Satlin A, et al. Head injury, bipolar disorder and response to valproate. Compr Psychiatry 1988; 29: 34–8

    Article  PubMed  Google Scholar 

  58. Bakchine S, Lacomblez C, Benoit N, et al. Manic-like states after orbitofrontal and right temporoparietal injury: efficacy of clonidine. Neurology 1989; 39: 777–81

    Article  PubMed  CAS  Google Scholar 

  59. Pleak RR, Birmaher B, Gavrileseu A, et al. Mania and neuropsychiatric excitement following carbamazepine. J Am Acad Child Adolesc Psychiatry 1988; 27: 500–3

    Article  PubMed  CAS  Google Scholar 

  60. Schiff HB, Sabrin TB, Geller A, et al. Lithium in aggressive behaviour. Am J Psychiatry 1982; 139: 1346–8

    PubMed  CAS  Google Scholar 

  61. Hornstein A, Seliger G. Cognitive side effects of lithium in closed head injury. J Neuropsychiatry Clin Neurosci 1989; 1: 446–7

    PubMed  CAS  Google Scholar 

  62. Parmelee DX, O’Shannick FJ. Carbamazepine-lithium toxicity in brain damaged adolescents. Brain Inj 1988; 2: 305–8

    Article  PubMed  CAS  Google Scholar 

  63. Calabrese JR, Bowden C, Woyshville MJ. Lithium and the anticonvulsants in the treatment of bipolar disorder. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995: 1099–111

    Google Scholar 

  64. Feeney D, Gonzales A, Law W. Amphetamine, haloperidol and experience interact to affect rate of recovery after motor cortex injury. Science 1982; 217: 855–7

    Article  PubMed  CAS  Google Scholar 

  65. Bernstein JG. Drug therapy in psychiatry. 3rd ed. St Louis: Mosby-Year Book, 1995

    Google Scholar 

  66. Hillbom E. After effects of brain injury. Acta Psychiatr Neurol Scand 1960; 142 Suppl.: 1–195

    Google Scholar 

  67. Achte KA, Hillbom E, Aalberg V. Post-traumatic psychoses following war brain injuries: reports from the Rehabilitation Institute for Brain Injured Veterans in Finland. Vol 1. Helsinki, 1967

  68. Achte KA, Hillbom E, Aalberg V Psychoses following war brain injuries. Acta Psychiatr Scand 1969; 45: 1–18

    Article  PubMed  CAS  Google Scholar 

  69. Ota Y Psychiatric studies on civilian head injuries. In: Walker AE, Caveness WF, Critchly M, editors. The late effects of head injury. Springfield (IL): Thomas, 1969

    Google Scholar 

  70. Lal S, Merbitz CP, Grip JC. Modification of function in head-injured patients with Sinemet. Brain Inj 1988; 2: 225–33

    Article  PubMed  CAS  Google Scholar 

  71. Leonard B. Fundamentals of psychopharmacology. Chichester: John Wiley and Sons, 1992

    Google Scholar 

  72. Stanislav SW Cognitive effects of antipsychotic agents in persons with traumatic brain injury. Brain Inj 1997; 11(5): 335–41

    Article  PubMed  CAS  Google Scholar 

  73. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment of resistant schizophrenia: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45: 789–96

    Article  PubMed  CAS  Google Scholar 

  74. Wolf B, Grohmann R, Schmidt LG, et al. Psychiatric admissions due to adverse drug reactions. Compr Psychiatry 1989; 30: 534–45

    Article  PubMed  CAS  Google Scholar 

  75. Roebush P, Stewart T. A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry 1989; 146: 717–25

    Google Scholar 

  76. Vincent FM, Zimmerman JF, van Hären J. Neuroleptic malignant syndrome complicating closed head injury. Neurosurg 1986; 18: 190–3

    Article  CAS  Google Scholar 

  77. Yassa R, Nair V, Schwartz G. Tardive dyskinesia and the primary psychiatric diagnosis. Psychosomatics 1984; 25: 135–8

    Article  PubMed  CAS  Google Scholar 

  78. Yassa R, Nair V, Schwartz G. Tardive dyskinesia: a two-year follow up study. Psychosomatics 1984; 25: 852–5

    Article  PubMed  CAS  Google Scholar 

  79. Meltzer HY. Atypical antipsychotic drugs. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995: 1277–86

    Google Scholar 

  80. Marin MS, Fogel BS, Hawkins J, et al. Apathy: a treatable syndrome. J Neuropsychiatry Clin Neurosci 1995; 7(1): 23–30

    PubMed  CAS  Google Scholar 

  81. Chandler MC, Barnhill JL, Gualtieri CT. Case studies: amantadine for the agitated head injury patient. Brain Inj 1988; 2: 309–11

    Article  PubMed  CAS  Google Scholar 

  82. Gualtieri CT, Chandler M, Coons TB, et al. Amantadine: a new clinical profile for traumatic brain injury. Clin Neuropharmacol 1989; 12: 258–70

    Article  PubMed  CAS  Google Scholar 

  83. Olanzapine product monograph. Eli Lilly and Company (NZ) Ltd., 1997

  84. Warden DL, Labbate LA, Salazar AM, et al. Post-traumatic stress disorder in patients with traumatic brain injury and amnesia forthe event? J Neuropsychiatry Clin Neurosci 1997; 9: 18–22

    PubMed  CAS  Google Scholar 

  85. Epstein RS, Ursano RJ. Anxiety disorders. In: Silver JM, Yudofsky SC, Hales RE, editors. Neuropsychiatry of traumatic brain injury. Washington, DC: American Psychiatric Press, 1994: 285–311

    Google Scholar 

  86. Adler A. Mental symptoms following head injury: a statistical analysis of two hundred cases. Arch Neurol Psychiatry 1945; 53: 34–43

    Google Scholar 

  87. Fallon S, Ryan C, Chamberlain K, et al. Tricyclics: possible treatment for post-traumatic stress disorder. J Clin Psychiatry 1985; 46: 385–9

    Google Scholar 

  88. Silver JM, Sandberg DP, Hales RE. New approaches in the pharmacotherapy of post-traumatic stress disorder. J Clin Psychiatry 1990; 51(10 Suppl.): 33–8

    Google Scholar 

  89. Hollander E, Cohen LJ.The assessment and treatment of refractory anxiety. J Clin Psychiatry 1994; 55(2 Suppl.): 27–31

    PubMed  Google Scholar 

  90. Zald DH, Kim SW. Anatomy and function of the orbital frontal cortex. I. Anatomy, neurocircuitry and obsessive compulsive disorder. J Neuropsychiatry Clin Neurosci 1996; 8(2): 125–38

    PubMed  CAS  Google Scholar 

  91. Zald DH, Kim SW. Anatomy and function of the orbital frontal cortex. II. Function and relevance to obsessive compulsive disorder. J Neuropsychiatry Clin Neurosci 1996; 8(3): 249–61

    PubMed  CAS  Google Scholar 

  92. Kant R, Smith-Semiller L, Duffy JD. Obsessive-compulsive disorder after closed head injury: a review of literature and report of four cases. Brain Inj 1996; 10(1): 55–63

    Article  PubMed  CAS  Google Scholar 

  93. Stein DJ, Hollander E, Leibowitz MR. Neurobiology of impulsivity and the impulse control disorders. J Neuropsychiatry Clin Neurosci 1993; 5: 9–17

    PubMed  CAS  Google Scholar 

  94. Jenike M. Pharmacologic treatment of obsessive-compulsive disorders. Psychiatr Clin North Am 1992; 15(4): 895–919

    PubMed  CAS  Google Scholar 

  95. Cahill L, Prins B, Weber M, et al. Beta adrenergic activation and memory for emotional events. Nature 1994; 371: 702–4

    Article  PubMed  CAS  Google Scholar 

  96. Versiani M, Mundim FD, Nardi AE, et al. Phenelzine in social phobia. J Clin Psychopharmacol 1988; 8: 279–83

    Article  PubMed  CAS  Google Scholar 

  97. Leibowitz MR, Schneier F, Campeas R, et al. Phenelzine vs antenolol in social phobia: a placebo-controlled comparison. Arch Gen Psychiatry 1992; 480: 290–300

    Google Scholar 

  98. Versiani M, Nardi AE, Mundim FD, et al. Pharmacotherapy of social phobia: a controlled study with moclobemide and phenelzine. Br J Psychiatry 1992; 161: 353–60

    Article  PubMed  CAS  Google Scholar 

  99. Trott GE, Friese HJ, Menzel M, et al. Use of moclobemide in children with attention deficit hyperactivity disorder. Psychopharmacology 1992; 106: 5134–6

    Article  Google Scholar 

  100. Goldstein K. After effects of brain injuries in war. New York: Grune and Stratton, 1942

    Google Scholar 

  101. Willer B, Corrigan JD. Whatever it takes: a model for community based services. Brain Inj 1994; 8(7): 647–59

    Article  PubMed  CAS  Google Scholar 

  102. Clark DM. Anxiety states: panic and generalised states. In: Hawton K, Salkouskis PM, Kirk J, et al. editors. Cognitive behavioural therapy for psychiatric problems: a practical guide. Oxford: Oxford University Press, 1989: 52–96

    Google Scholar 

  103. Solyom L, Solyom C, Ledwidge B. Fluoxetine in panic disorder. Can J Psychiatry 1991; 36: 378–80

    PubMed  CAS  Google Scholar 

  104. Black DW, Wesner R, Bowers W, et al. A comparison of fluoxetine, cognitive therapy and placebo in the treatment of panic disorder. Arch Gen Psychiatry 1993; 50: 44–50

    Article  PubMed  CAS  Google Scholar 

  105. Newburn GM. Psychological problems after disability: recognition and management. Patient Manage NZ 1996; 25(9): 17–24

    Google Scholar 

  106. Gualtieri CT, Evans RW. Stimulant treatment for neuro-behavioural sequelae of traumatic brain injury. Brain Inj 1988; 2: 273–90

    Article  PubMed  CAS  Google Scholar 

  107. Lipper S, Tuchman MM. Treatment of chronic post-traumatic organic brain syndrome with dextroamphetamine: first reported case. J Nerv Ment Dis 1976; 162: 266–71

    Article  Google Scholar 

  108. Evans RW, Gualtiera CT, Patterson D. Treatment of chronic closed head injury with psychostimulant drugs: a controlled case study and an appropriate evaluation procedure. J Nerv Ment Dis 1987; 187: 106–10

    Google Scholar 

  109. Pannelee DX, O’Shannick GJ. Neuropsychiatric interventions with head-injured children and adolescents. Brain Inj 1987; 1: 41–7

    Article  Google Scholar 

  110. Gualtieri CT. Buspirone: neuropsychiatric effects. J Head Trauma Rehabil 1991; 6(1): 90–2

    Article  Google Scholar 

  111. Shader RD, Greenblatt DJ. The pharmacotherapy of acute anxiety: a mini update. In: Bloom FE, Kupter DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995: 1341–8

    Google Scholar 

  112. Nickels JA, Schneider WH, Dombouy ML, et al. Clinical use of amantadine in brain injury rehabilitation. Brain Inj 1994; 8(8): 709–18

    Article  PubMed  CAS  Google Scholar 

  113. van Reekum R, Bayley M, Garner S, et al. N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury. Brain Inj 1995; 9(1): 49–53

    Article  PubMed  Google Scholar 

  114. Crimson ML, Childs A, Wilcox RE, et al. The effect of bromocriptine on speech dysfunction in patients with diffuse brain injury (akinetic mutism). Clin Neuropharmacol 1988; 11: 462–6

    Article  Google Scholar 

  115. Eames P. The use of Sinemet and bromocriptine. Brain Inj 1989; 3: 319–20

    Article  PubMed  CAS  Google Scholar 

  116. Gupta SR, Mlcoch AG. Bromocriptine treatment of non-fluent aphasia. Arch Phys Med Rehabil 1992; 73: 373–6

    Article  PubMed  CAS  Google Scholar 

  117. Parks RW, Crocker DJ, Manje HK, et al. Assessment of bromocriptine interventions for the treatment of frontal lobe syndrome: a case study. J Neuropsychiatry Clin Neurosci 1992; 4: 109–10

    PubMed  CAS  Google Scholar 

  118. Wolf AP, Gleckman AD. Sinemet and brain injury: function versus statistical change and suggestions for future research design. Brain Inj 1995; 9(5): 487–93

    Article  PubMed  CAS  Google Scholar 

  119. Bleiberg J, Garmoe W, Cedarquist J, et al. Effects of Dexedrine on performance consistency following brain injury. Neuropsychiatry Neuropsychol Behav Neurol 1993; 6: 245–8

    Google Scholar 

  120. Speech TJ, Rao SM, Osmon DC, et al. A double-blind controlled study of methylphenidate treatment in closed head injury. Brain Inj 1993; 7: 333–8

    Article  PubMed  CAS  Google Scholar 

  121. Kraus MF. Neuropsychiatric sequelae of stroke and traumatic brain injury: the role of psychostimulants. Int J Psychiatry Med 1995; 25: 39–51

    Article  PubMed  CAS  Google Scholar 

  122. Hornstein A, Lennihan L, Seliger G, et al. Amphetamine in recovery from brain injury. Brain Inj 1996; 10(2): 145–8

    Article  PubMed  CAS  Google Scholar 

  123. Feeney DM, Sutton RL. Pharmacotherapy for recovery of function after brain injury. CRC Crit Rev Clin Neurobiol 1997; 3: 135–97

    Google Scholar 

  124. Evans RW, Gualtieri CT, Amara I. Methylphenidate and memory: dissociated effects in hyperactive children. Psychopharmacology 1986; 90: 211–6

    Article  PubMed  CAS  Google Scholar 

  125. Hovda DA, Feeney DM. Amphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat. Brain Res 1984; 298: 358–91

    Article  PubMed  CAS  Google Scholar 

  126. Gold PE, Delanoy RL, Merrin J. Modulation of long term potentiation by peripherally administered amphetamine and epinephrine. Brain Res 1984; 305: 103–7

    Article  PubMed  CAS  Google Scholar 

  127. Uranova NA, Klinzova AJ, Istomin VV, et al. The effects of amphetamine on synaptic plasticity in rat’s medial prefrontal cortex. J Hirnforschung 1989; 30: 45–50

    CAS  Google Scholar 

  128. Sutton RL, Hovda DA, Feeney DM. Amphetamine accelerates recovery of locomotor function following bilateral frontal cortex ablation in cats. Behav Neurosci 1989; 103: 837–41

    Article  PubMed  CAS  Google Scholar 

  129. Dietrich WD, Alonso O, Busto R, et al. Influence of amphetamine treatment on somatosensory function of the normal and infarcted rat brain. Stroke 1990; 21 Suppl. 111: 147–50

    Google Scholar 

  130. Wroblewski B, Leary J, Whelan A, et al. Methylphenidate and seizure frequency in brain-injured patients. J Clin Psychiatry 1992; 53: 86–9

    PubMed  CAS  Google Scholar 

  131. Wood RL. Towards a model of cognitive rehabilitation. In: Wood RL, Fussey I, editors. Cognitive rehabilitation in perspective. London: Taylor and Francis, 1990: 3–25

    Google Scholar 

  132. McKinlay WW, Brooks DN, Bond MR, et al. The short term outcomes of severe blunt head injury as reported by the relatives of the injured person. J Neurol Neurosurg Psychiatry 1981; 44: 527–33

    Article  PubMed  CAS  Google Scholar 

  133. Dikmen S, Machamer J, Temkin N. Psychosocial outcome in patients with moderate to severe head injury: 2 year follow-up. Brain Inj 1993; 7(2): 113–24

    Article  PubMed  CAS  Google Scholar 

  134. Lewis DD, Pincus JF, Bard D, et al. Neuropsychiatric, psychoeducational and family characteristics of 14 juveniles condemned to death in the United States. Am J Psychiatry 1988; 145: 584–9

    PubMed  CAS  Google Scholar 

  135. Rosenbaum A, Hose SR. Head injury and marital aggression. Am J Psychiatry 1989; 146(8): 1048–51

    PubMed  CAS  Google Scholar 

  136. Elliott FA. Neurological findings in adult minimal brain dysfunction and the dyscontrol syndrome. J Nerv Ment Dis 1982; 170: 680–7

    Article  PubMed  CAS  Google Scholar 

  137. Wills RG, Young JPR, Thomas DJ. Kleine-Levin syndrome: report of two cases with onset of symptoms precipitated by head trauma. Br J Psychiatry 1988; 152: 410–2

    Article  Google Scholar 

  138. Stewart JT. Akathisia following traumatic brain injury: treatment with bromocriptine. J Neurol Neurosurg Psychiatry 1989; 52: 1200–1

    Article  PubMed  CAS  Google Scholar 

  139. Fornazzari L, Farlnik K, Smith I, et al. Violent visual hallucinations and aggression in frontal lobe dysfunction: clinical manifestations of deep orbitofrontal foci. J Neuropsychiatry Clin Neurosci 1992; 4: 42–4

    PubMed  CAS  Google Scholar 

  140. Eichelman B. Aggressive behaviour: from laboratory to clinic. Arch Gen Psychiatry 1992; 49: 488–99

    Article  PubMed  CAS  Google Scholar 

  141. Devinsky O, Kernan J, Bear DM. Aggressive behaviour following exposure to cholinesterase inhibitors. J Neuropsychiatry Clin Neurosci 1992; 4: 189–94

    PubMed  CAS  Google Scholar 

  142. Siegel A. Neuroanatomical and neurochemical mechanisms that underlie defensive rage and aggression in the cat: role of the amygdala. Neuropsychopharmacology 1994; 10(35): 375

    Google Scholar 

  143. Pletnikov MV. The participation of the octapeptide cholecystokinin and beta-endorphin in the neurochemical support of the interspecific and intraspecific aggressivity of rats. Zh Vyssh Nerv Deiat Im I P Pavlova 1989; 39: 770–3

    PubMed  CAS  Google Scholar 

  144. Depaulis A, Keay K, Badler R. Neuronal organisation of defensive strategies in the periaqueductal grey matter. Neuropsychopharmacology 1994; 10(3): 408

    Google Scholar 

  145. Newburn GM. Impulse control and aggression following head injury. Paper presented at Canadian Brain Injury Coalition Annual Meeting, Calgary, 1995 Jun 1–3

  146. O’Neill M, Page N, Adkins WH, et al. Tryptophan-trazodone treatment of aggressive behaviour. Lancet 1986; II: 859–60

    Article  Google Scholar 

  147. Simpson DM, Foster D. Improvement in organically disturbed behaviour with trazodone treatment. J Clin Psychiatry 1986; 47: 191–3

    PubMed  CAS  Google Scholar 

  148. Pinner E, Rich CL. Effects of trazodone on aggressive behaviour in seven patients with organic mental disorders. Am J Psychiatry 1988; 145: 1295–6

    PubMed  CAS  Google Scholar 

  149. Sobin P, Schneider L, McDermott H. Fluoxetine treatment of impulsive aggression in DSM-3-R personality disorder patients. J Clin Psychopharmacol 1990; 10: 373–5

    Google Scholar 

  150. Coccaro EF, Astill JL, Herbert JL, et al. Fluoxetine treatment of impulsive aggression in DSM-3-R personality disorder patients. J Clin Psychopharmacol 1990; 10: 373–5

    Article  PubMed  CAS  Google Scholar 

  151. Seliger GM, Hornstein A, Flax J, et al. Fluoxetine improves emotional continence. Brain Inj 1992; 6: 267–70

    Article  PubMed  CAS  Google Scholar 

  152. Sloan RL, Brown KW, Pentland B. Fluoxetine as a treatment for emotional lability after brain injury. Brain Inj 1992; 6: 315–9

    Article  PubMed  CAS  Google Scholar 

  153. Hornstein A, Seliger G, Flax J, et al. Fluoxetine in treating emotional lability [letter]. Brain Inj 1993; 7(2): 189

    Article  PubMed  CAS  Google Scholar 

  154. Haas JP, Cope N. Neuropharmacologic management of behaviour sequelae in head injury: a case report. Arch Phys Med Rehabil 1985; 66: 472–4

    PubMed  CAS  Google Scholar 

  155. Yudofsky SC, Silver JM, Schneider SE. Pharmacologic treatment of aggression. Psychiatr Ann 1987; 17: 397–407

    Google Scholar 

  156. Elliott FA. Propranolol for the control of belligerent behaviour following acute brain damage. Ann Neurol 1977; 1: 489–91

    Article  PubMed  CAS  Google Scholar 

  157. Yudofsky SC, Williams D, Gorman J. Propranolol in the treatment of rage and violent behaviour in patients with chronic brain syndromes. Am J Psychiatry 1981; 138: 218–20

    PubMed  CAS  Google Scholar 

  158. Hjorth S, Carlsson A. Is pindolol a mixed agonist/antagonist at central serotonin receptors. Eur J Pharmacol 1986; 129: 131–8

    Article  PubMed  CAS  Google Scholar 

  159. Mooney GF, Haas LJ. Effect of methylphenidate on brain injury-related anger. Arch Phys Med Rehabil 1993; 74: 153–60

    PubMed  CAS  Google Scholar 

  160. Gleason RP, Schneider LS. Carbamazepine treatment of agitation in Alzheimer’s patients refractory to neuroleptics. J Clin Psychiatry 1990; 51: 115–88

    PubMed  CAS  Google Scholar 

  161. Silver JM, Yudofsky SC. Aggressive disorders. In: Silver JM, Yudofsky SC, Hales RE, editors. Neuropsychiatry of traumatic brain injury. Washington, DC: American Psychiatric Press, 1994: 313–53

    Google Scholar 

  162. Giakas WJ, Seibyl JP, Mazure CM. Valproate in the treatment of temper outbursts. J Clin Psychiatry 1990; 51: 525

    PubMed  CAS  Google Scholar 

  163. Wrobleswki BA, Joseph AB, Kupfer J, et al. Effectiveness of valproic acid on destructive and aggressive behaviours in patients with acquired brain injury. Brain Inj 1997; 11(1): 37–47

    Article  Google Scholar 

  164. Herrera JN, Sramek JJ, Costs JF, et al. High potency neuroleptics and violence in schizophrenia. J Nerv Ment Dis 1988; 176: 558–61

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rotorua Rehabilitation Clinic, PO Box 614, Rotorua, New Zealand

    Gil Newburn

Authors
  1. Gil Newburn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Newburn, G. Psychiatric Disorders Associated with Traumatic Brain Injury. Mol Diag Ther 9, 441–456 (1998). https://doi.org/10.2165/00023210-199809060-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-199809060-00003

Keywords

Search

Navigation